US Patent Issued to OncoC4 on Nov. 18 for "Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof" (District Of Columbia, Maryland Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,362, issued on Nov. 18, was assigned to OncoC4 Inc. (Rockville, Md.).

"Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof" was invented by Yang Liu (Washington), Pan Zheng (Washington) and Martin Devenport (Gaithersburg, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to compositions of chimeric and humanized antibodies that bind to the human CTLA4 molecule and their use in cancer immunotherapy and for reduction of autoimmune side effects compared to other immunotherapeutic agents."

The patent was filed on March 22, 2023, under Application No. 18/188,098.

*For further information, including ima...